Works matching AU Harnett, Paul

Results: 73
    1
    2
    3
    4
    5
    6
    7

    Comparison of Expression Profiles in Ovarian Epithelium In Vivo and Ovarian Cancer Identifies Novel Candidate Genes Involved in Disease Pathogenesis.

    Published in:
    PLoS ONE, 2011, v. 6, n. 3, p. 1, doi. 10.1371/journal.pone.0017617
    By:
    • Emmanuel, Catherine;
    • Gava, Natalie;
    • Kennedy, Catherine;
    • Balleine, Rosemary L.;
    • Sharma, Raghwa;
    • Wain, Gerard;
    • Brand, Alison;
    • Hogg, Russell;
    • Etemadmoghadam, Dariush;
    • George, Joshy;
    • Birrer, Michael J.;
    • Clarke, Christine L.;
    • Chenevix-Trench, Georgia;
    • Bowtell, David D. L.;
    • Harnett, Paul R.;
    • deFazio, Anna
    Publication type:
    Article
    8
    9
    10
    11
    12

    ABCA Transporter Gene Expression and Poor Outcome in Epithelial Ovarian Cancer.

    Published in:
    JNCI: Journal of the National Cancer Institute, 2014, v. 106, n. 7, p. 1, doi. 10.1093/jnci/dju149
    By:
    • Hedditch, Ellen L.;
    • Bo Gao;
    • Russell, Amanda J.;
    • Yi Lu;
    • Emmanuel, Catherine;
    • Beesley, Jonathan;
    • Johnatty, Sharon E.;
    • Xiaoqing Chen;
    • Harnett, Paul;
    • George, Joshy;
    • Williams, Rebekkal;
    • Flemming, Claudia;
    • Lambrechts, Diether;
    • Despierre, Evelyn;
    • Lambrechts, Sandrina;
    • Vergote, Ignace;
    • Karlan, Beth;
    • Lester, Jenny;
    • Orsulic, Sandra;
    • Walsh, Christine
    Publication type:
    Article
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23

    I now wear a white coat.

    Published in:
    Medical Journal of Australia, 2001, v. 175, n. 4, p. 228, doi. 10.5694/j.1326-5377.2001.tb143116.x
    By:
    • Harnett, Paul R
    Publication type:
    Article
    24

    Should doctors wear white coats?

    Published in:
    Medical Journal of Australia, 2001, v. 174, n. 7, p. 343, doi. 10.5694/j.1326-5377.2001.tb143310.x
    By:
    • Harnett, Paul R
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    A randomized phase III study evaluating pegylated liposomal doxorubicin versus capecitabine as first-line therapy for metastatic breast cancer: results of the PELICAN study.

    Published in:
    Breast Cancer Research & Treatment, 2017, v. 161, n. 1, p. 63, doi. 10.1007/s10549-016-4033-3
    By:
    • Harbeck, Nadia;
    • Saupe, Steffen;
    • Jäger, Elke;
    • Schmidt, Marcus;
    • Kreienberg, Rolf;
    • Müller, Lothar;
    • Otremba, Burkhard;
    • Waldenmaier, Dirk;
    • Dorn, Julia;
    • Warm, Mathias;
    • Scholz, Michael;
    • Untch, Michael;
    • Wit, Maike;
    • Barinoff, Jana;
    • Lück, Hans-Joachim;
    • Harter, Philipp;
    • Augustin, Doris;
    • Harnett, Paul;
    • Beckmann, Matthias;
    • Al-Batran, Salah-Eddin
    Publication type:
    Article
    48
    49
    50